a developer of RNAi-based medical technologies and therapies
Industry Biotechnology
A.I.dvisor indicates that over the last year, PHIO has been closely correlated with RIGL. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if PHIO jumps, then RIGL could also see price increases.
Ticker / NAME | Correlation To PHIO | 1D Price Change % | ||
---|---|---|---|---|
PHIO | 100% | -2.94% | ||
RIGL - PHIO | 84% Closely correlated | -2.38% | ||
CLNN - PHIO | 83% Closely correlated | +12.33% | ||
HOOK - PHIO | 81% Closely correlated | -2.49% | ||
DARE - PHIO | 81% Closely correlated | +0.56% | ||
AZTR - PHIO | 74% Closely correlated | -7.75% | ||
More |
Ticker / NAME | Correlation To PHIO | 1D Price Change % |
---|---|---|
PHIO | 100% | -2.94% |
PHIO (9 stocks) | 27% Poorly correlated | -0.08% |
therapy (24 stocks) | 8% Poorly correlated | +1.03% |
drugs (265 stocks) | 7% Poorly correlated | +5.37% |
biotechnology (248 stocks) | 2% Poorly correlated | +5.56% |